<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00210093</url>
  </required_header>
  <id_info>
    <org_study_id>08-106</org_study_id>
    <nct_id>NCT00210093</nct_id>
  </id_info>
  <brief_title>A Pharmacokinetic Evaluation Study in Healthy Volunteers</brief_title>
  <official_title>A Single-Center, Randomized, Crossover Pharmacokinetic Evaluation of the Effect of Single Doses of Intravenous INS37217, Nasally Inhaled INS37217 and Orally Inhaled INS37217 Solution in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      The purpose of this trial is to characterize the pharmacokinetics of INS37217 following
      intravenous, intranasal, and inhalation administration and to calculate the relative
      bioavailability of INS37217 when administered via oral or nasal inhalation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">May 2003</completion_date>
  <primary_completion_date type="Actual">May 2003</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma concentrations of INS37217</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pilot study - not specified</measure>
  </secondary_outcome>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>denufosol tetrasodium (INS37217)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Are current nonsmokers or previous smokers who have not smoked within 6 months and who
             do not have greater than or equal to a 10 pack-year history of tobacco use

          -  Are within 20% of their ideal body weight

          -  Are healthy on the basis of a pre-trial physical examination

        Exclusion Criteria:

          -  History or suspicion of recent alcohol, barbiturate, amphetamine or narcotic abuse or
             a positive urine drug test at study screening

          -  History of cardiac arrhythmias, any pathological abnormality on the ECG, bronchospasm,
             diabetes mellitus, thyrotoxicosis, Parkinsonism, asthma, COPD or cardiovascular
             disease significant drug allergy

          -  Subject with a physical obstruction in the nose

          -  Use of concomitant medication other than hormonal contraceptives and multi-vitamins

          -  Subjects with a current upper respiratory illness or infection for the 2 weeks prior
             to screening or any chronic respiratory illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Amy Schaberg, BSN</last_name>
    <role>Study Director</role>
  </overall_official>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>October 15, 2015</last_update_submitted>
  <last_update_submitted_qc>October 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

